<DOC>
	<DOCNO>NCT00419653</DOCNO>
	<brief_summary>The study aim investigate modulation regional brain activation schizophrenic patient psychopharmacological treatment either haloperidol , amisulpride olanzapine . The study perform functional magnetic resonance imaging ( fMRI ) diffusion tensor imaging ( DTI ) .</brief_summary>
	<brief_title>Modulation Regional Brain Activation Schizophrenic Patients Pharmacological Therapy</brief_title>
	<detailed_description>The current study aim investigate follow issue : - Changes cognitive activation pattern therapy typical neuroleptic haloperidol compare atypical antipsychotic amisulpride olanzapine - Relationship change activity psychopathological , neuropsychological pharmacotherapeutic variable ( e.g . drug plasma level ) well certain biological marker ( HVA , prolactin ) - Relationship diffusion anisotropy indicator structural connectivity cognitive activation pattern antipsychotic treatment</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>In outpatient either sex Able comply protocol Having give write informed consent free Total BPRS ( PANSSderived , 17 point ) minimum 36 point baseline Schizophrenic schizophreniform disorder accord DSMIV criterion ( 295.10 , .30 , .40 , .90 ) Definite righthandedness ( accord modify Edinburgh Handedness Inventory ) Age 18 50 year Comorbid psychiatric axis I disorder ( DSMIV ) schizophrenia Axis II disorder accord DSMIV Present past history substance drug dependence ( include alcohol dependence ) Participation clinical trial within previous three month Lack insight Suicidal ideation aggression others Consumption caffeinecontaining beverage within 6 hour assessment Clinically significant finding ECG EEG Known intolerance neuroleptic</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>schizophrenia fMRI drug therapy amisulpride</keyword>
</DOC>